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ABSTRACT 37 
 38 
Background: Delirium has been associated with more rapid cognitive decline. However, it is 39 
unknown whether increased delirium severity is associated with a higher rate of long-term 40 
cognitive decline.  41 
Objective: To evaluate delirium severity and the presence and rate of cognitive decline over 36 42 
months following surgery.  43 
Methods: We examined patients from the Successful Aging after Elective Surgery Study, who 44 
were age ≥70 years undergoing major elective surgery (N=560). Delirium severity was 45 
determined by the peak Confusion Assessment Method-Severity (CAM-S) score for each 46 
patient’s hospitalization and grouped based on the sample distribution: scores of 0-2, 3-7, and 47 
8-19. A neuropsychological composite, General Cognitive Performance (GCP), and proxy-48 
reported Informant Questionnaire for Cognitive Decline (IQCODE) were used to examine 49 
cognitive outcomes following surgery at 0, 1, 2 months, and every 6 months for up to 3 50 
years. 51 
Results: No significant cognitive decline was observed for patients with peak CAM-S scores 0-2 52 
(-0.17 GCP units/year, 95% confidence interval [CI] -0.35, 0.01). GCP scores decreased 53 
significantly in the group with peak CAM-S scores 3-7 (-0.30 GCP units/year, 95% CI  54 
 -0.51, -0.09), and decreased almost three times faster in the highest delirium severity group 55 
(peak CAM-S scores 8-19; -0.82 GCP units/year, 95% CI -1.28, -0.37). A similar association 56 
was found for delirium severity and the proportion of patients who developed IQCODE 57 
impairment over time.   58 
Conclusion: Patients with the highest delirium severity experienced the greatest rate of cognitive 59 
decline, which exceeds the rate previously observed for patients with dementia, on serial 60 
 
 
3 
 
neuropsychological testing administered over 3 years, with a dose-response relationship 61 
between delirium severity and long-term cognitive decline.  62 
Key words: delirium, cognition, dementia, aged  63 
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INTRODUCTION 64 
 65 
Delirium is a common and serious problem for hospitalized older persons, associated 66 
with prolonged hospital stays, higher hospital costs, increased functional decline, higher rates of 67 
institutionalization, and greater mortality [1, 2]. There is growing evidence that delirium is 68 
associated with a subsequent course of more rapid cognitive decline [3]. Among patients 69 
undergoing cardiac surgery, delirium is associated with a significant decline in cognitive ability, 70 
with a trajectory characterized by an initial decline and prolonged impairment [4]. Moreover, 71 
patients with Alzheimer’s disease (AD) have a 3-fold increase in the rate of cognitive decline 72 
following delirium, compared with those without delirium [5, 6]. In patients without dementia at 73 
baseline, those who experienced delirium demonstrated a 4.3-fold greater decline in long-term 74 
cognitive performance than the effect of a year of cognitive aging [7]. Although this study [7] 75 
and others [8-10] demonstrate that incident delirium is associated with long-term cognitive 76 
decline, the critical next step to advance understanding of this relationship is to evaluate whether 77 
the severity of delirium is associated with the pace of long-term cognitive decline. This would 78 
prove useful for monitoring delirium clinically and for providing a quantifiable dose-response 79 
measure for intervention trials seeking to prevent or forestall the long-term cognitive decline 80 
associated with delirium. 81 
 We have previously shown that delirium severity, as measured by the Confusion 82 
Assessment Method-Severity (CAM-S) score [11], demonstrated strong predictive validity for 83 
important short-term clinical outcomes associated with delirium, including hospital length of 84 
stay, healthcare costs, death, institutionalization, and functional decline [11]. Thus, the Aim of 85 
this study was to evaluate whether the severity of delirium was associated with the presence and 86 
degree of cognitive decline up to 36 months post-surgery in patients who are free of dementia at 87 
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baseline. We hypothesized that there would be a graded relationship, with increasing severity of 88 
delirium associated with increasing degrees of long-term cognitive decline.  89 
 90 
MATERIALS AND METHODS 91 
 92 
Study Population 93 
The Successful Aging after Elective Surgery (SAGES) Study is an ongoing prospective 94 
cohort study of older adults undergoing major elective non-cardiac surgery. The study design and 95 
methods have been previously described [12]. Briefly, eligible participants were age ≥70 years, 96 
English speaking, scheduled for elective surgery at one of two Harvard-affiliated academic 97 
medical centers with an anticipated length of stay ≥3 days. Eligible surgical procedures were: 98 
total hip or knee replacement, lumbar, cervical, or sacral laminectomy, lower extremity arterial 99 
bypass surgery, open abdominal aortic aneurysm repair, and colectomy. Exclusion criteria 100 
included evidence of dementia, delirium, hospitalization within 3 months, terminal condition, 101 
legal blindness, severe deafness, history of schizophrenia or psychosis, and history of alcohol 102 
abuse or withdrawal. A total of 566 patients were eligible and enrolled between June 18, 2010 103 
and August 8, 2013. Six patients were subsequently excluded for possible dementia after 104 
neuropsychological testing and clinical adjudication (final sample=560; see STROBE diagram 105 
and follow-up success rates in the Appendix). This study is in compliance with guidelines on 106 
ethical principles for medical research involving human subjects. Written informed consent for 107 
study participation was obtained from all participants according to procedures approved by the 108 
institutional review boards of Beth Israel Deaconess Medical Center and Brigham and Women’s 109 
Hospital, the two study hospitals, and Hebrew SeniorLife, the study coordinating center, all 110 
located in Boston, Massachusetts. 111 
 112 
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Study Procedures 113 
Trained research assistants conducted a 90-minute baseline interview in participants’ 114 
homes about 2 weeks prior to the index surgery [12, 13]. Following surgery, daily interviews 115 
were conducted to assess for delirium. After discharge, home-based interviews were conducted 116 
by a separate group of trained research assistants (blinded to delirium status) at 1, 2, 6, and every 117 
six months up to 36 months. Interviews included assessments of delirium, cognitive and physical 118 
function, described below. Medical records were reviewed for the index hospitalization and 119 
readmissions.   120 
 121 
Main Study Measures 122 
Delirium. The Confusion Assessment Method (CAM) [14] was used to identify delirium 123 
at all time points. The CAM provides a standardized method for identification of delirium, with a 124 
sensitivity of 94% (95% confidence interval (CI) 91%-97%), specificity of 89% (95% CI 85%-125 
94%), and inter-rater reliability of 0.70-1.00 [15]. All interviewers underwent training and 126 
standardization, and inter-rater reliability was determined in 71-paired observations (weighted 127 
kappa=0.92) [14]. Delirium was defined as either a positive rating by CAM or by a validated 128 
chart review method [16, 17], used to maximize sensitivity.   129 
Delirium Severity. The 10-item CAM-S long-form was used to measure delirium severity 130 
[11]. Each symptom was rated 0 to 2, except acute onset or fluctuation, which is rated 0 or 1 131 
[11], yielding a summary score from 0 to 19 (19=most severe). Because individual patients had 132 
multiple CAM ratings during hospitalization, we utilized the highest CAM-S score (peak CAM-133 
S) across all hospital days for each patient to capture the severity of the delirium episode. Peak 134 
CAM-S scores (range 0-19) were divided into three groups. Since a minimum of 3 features is 135 
required for CAM delirium, the lowest grouping included peak CAM-S scores of 0-2, 136 
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representing the group without CAM-defined delirium. While the majority of patients without 137 
delirium had a score of 0-2, some patients without delirium received higher scores based on non-138 
specific delirium features (e.g., disorientation, memory impairment, psychomotor agitation), 139 
which can be present in conditions unrelated to delirium. Next, the group with delirium (N=134) 140 
was divided into two groups based on the median peak CAM-S score. These steps allowed 141 
delirium patients to be spread across a range of sub-groups rather than clustering only in the 142 
highest group, an approach that is preferred when the sample is imbalanced across the 143 
distribution [16]. Thus, a single, median-based cutpoint was applied to our patients with SAGES 144 
delirium (N=134) (Table 1), resulting in two delirium groups with CAM-S scores of: 1) 3-7 (N= 145 
67),  and 2) 8-19 (N= 66).These cutpoints were then applied across the entire SAGES cohort.  146 
Cognitive Outcome Measures: General Cognitive Performance (GCP) and Informant 147 
Questionnaire on Cognitive Decline in the Elderly (IQCODE).  A neuropsychological test 148 
battery, conducted at baseline and each follow-up, included the Visual Search and Attention Test 149 
(VSAT) [20], Hopkins Verbal Learning Test-Revised (HVLT-R) [21], Digit Span Forward and 150 
Backward [22], Category Fluency (animal naming) [23] Phonemic F-A-S Fluency Tasks [23], 151 
Boston Naming Test (BNT) [24], Repeatable Battery for the Assessment of Neuropsychological 152 
Status (RBANS) Digit Symbol Substitution Test, Trail-Making Tests (Trails) A and B, and 153 
intersecting pentagons from the 3MS [25]. We created a weighted composite summary measure, 154 
the GCP score following standard procedures (see [26] for a detailed description). We assessed 155 
its reliability and validity and calibrated the GCP score to a nationally representative sample of 156 
adults age ≥70 years [27] to yield a mean score=50 and standard deviation=10 [25] to improve 157 
our ability to make meaningful comparisons to other study populations. The GCP is sensitive to 158 
longitudinal change with minimal floor and ceiling effects [26, 28-30].    159 
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To account for practice effects, GCP scores were adjusted with a correction factor 160 
derived from a control sample of comparable non-surgical patients (N=119) from a primary care 161 
clinic, who were administered the identical tests on the same schedule (Appendix). Using an 162 
accepted approach [31-33], the mean performance of the control sample at each time point was 163 
used to center the observed scores in the surgical sample at matching time points. This control 164 
group was used only to correct for retest (learning) effects.   165 
We used IQCODE [34] as a proxy-reported measure of decline in current abilities for 166 
daily cognitive tasks (range 1-5). IQCODE ≥3.2 was used to indicate impairment [34]. 167 
Death and Nursing Home Placement. We examined death or nursing home placement, 168 
obtained from patient/proxy interviews and chart review, as a composite outcome between 6-36 169 
months follow-up. This timeframe was chosen to indicate long-term outcomes, minimizing acute 170 
effects of surgery, hospitalization, or rehabilitation.  171 
Other Study Variables. The baseline interview assessed sex, race, ethnicity, education, 172 
marital status, living situation, 15-item Geriatric Depression Scale (GDS) [35], Modified Mini-173 
Mental State (3MS) [25], Activities of Daily Living Scale (ADLs) [36], Instrumental Activities 174 
of Daily Living Scale (IADLs) [37], and Short Form-12 Health Survey (SF-12) [38]. Age, 175 
surgical type, and Charlson comorbidity score [39] were determined from chart review [38].  176 
 177 
Statistical Analyses 178 
The overall analytic approaches used general linear mixed effects regression models for 179 
the trajectories of GCP score over time. Logistic regression was used for analysis of IQCODE 180 
impairment and nursing home placement or death. For GCP, the model included control for 181 
delirium severity group, with random effects for baseline GCP level, fixed effects at the 1 and 2 182 
month assessments to capture acute decline and recovery, and random effects for linear change 183 
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after the 2-month follow-up. The delirium severity group variable and the acute decline, 184 
recovery, and linear change were regressed on baseline GCP to capture differential effects by 185 
baseline status. Therefore, delirium severity group was treated as both an intermediate outcome 186 
(dependent upon baseline GCP and covariates) and as a predictor of model parameters capturing 187 
GCP change following baseline. Change over time was modeled using a three-part piecewise 188 
linear model to describe the longitudinal pattern, including an immediate decline following pre-189 
operative baseline to month 1 (acute decline), recovery from month 1 to 2 following the acute 190 
decline (recovery) and long-term trajectory from month 2 to 36 months (long-term trajectory) 191 
(Appendix). All models adjusted for baseline covariates, including age, gender, non-white race, 192 
education, Charlson score, GDS score, IADL impairment, surgery type, and IQCODE. Analyses 193 
were conducted with Mplus (Version 7.4, Muthén & Muthén, Los Angeles, CA).  194 
For IQCODE, we used a mixed effects generalized linear model with IQCODE 195 
impairment as a repeated outcome at all timepoints. A random effect for the linear slope captured 196 
variability in the change over time. For death or nursing home placement, logistic regression was 197 
used to model the probability of a participant having the composite of either outcome occurring 198 
between months 6–36.  Delirium severity was entered as a series of categorical indicators. An 199 
interaction between time and delirium severity group captured the differences in linear change 200 
over time by severity group. For the death or nursing home analyses with IQCODE, the adjusted 201 
models controlled for age, gender, non-white race, education, Charlson score, and surgery type. 202 
Baseline IADL and IQCODE were not controlled due to collinearity. Analyses were conducted 203 
with Stata software (Version 14.1, Stata Corp, College Station, TX). In analyzing this 204 
longitudinal data, our approach to handling data missing at random (MAR) aligns with 205 
recommendations by the National Research Council [55].  206 
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Sensitivity analyses were completed to: (1) assess the extent to which our findings were 207 
robust to extreme assumptions regarding cognitive outcomes of persons who left the cohort early 208 
due to drop-out, death, or institutionalization (Appendix), and (2) assess the relationship between 209 
long-term cognitive decline and sum of all CAM-S scores (an alternate measure of delirium 210 
severity that combines both intensity and duration of the delirium episode) [18] (Appendix).  211 
 212 
RESULTS 213 
 214 
Table 1 reports baseline characteristics overall and stratified by delirium severity group. 215 
The mean age was 76.7 years, and 58% were women. Delirium occurred in 24%. Forty-four 216 
percent had a peak CAM-S score of 0-2; 44% with peak scores of 3-7; and 12% with peak scores 217 
of 8-19. Patients with the most severe delirium (peak CAM-S 8-19) were older, had greater 218 
impairment on the Charlson, and lower GCP, 3MS, and GDS (all p<0.05). The Spearman rank 219 
correlation coefficients indicating the correlation of each variable with the peak CAM-S score 220 
are all trivial to moderate in size.  221 
The median duration of follow-up for this ongoing cohort was 36 months (interquartile 222 
range [IQR] 24-37). Deaths occurred in 7% of patients after a median follow-up of 19 months 223 
(IQR 12-26). An additional 27 (5%) participants withdrew from follow-up (i.e., drop-outs) after 224 
a median of 5 months (IQR 3-12). Rates of death or drop-out differed between the CAM-S 225 
groups, and increased with CAM-S severity level (8%, 12%, and 22% respectively, p=0.01) A 226 
total of 496 (89%) eligible participants completed all planned study visits, with a range of 1-9 227 
visits per participant. Since this is an ongoing study, the number of visits completed per 228 
participant varies according to how long they have been enrolled in the study. 229 
We examined cognitive performance by GCP up to 36 months post-surgery (Table 2) by 230 
delirium severity. For all groups, GCP scores declined acutely at one month, returned to baseline 231 
or above by two months, then remained stable to 3 years, except for the highest severity group 232 
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(peak CAM-S =8-19), who experienced progressive decline to 3 years from a mean GCP of 53.8 233 
at baseline to 51.8 at 36 months (2.0 average point decline).    234 
Figure 1 shows the effect of GCP performance over time by delirium severity group. All 235 
three groups experienced decline 1 month post-surgery and recovered to baseline or above. The 236 
lowest severity group (peak CAM-S=0-2) had no significant decline over months 2-36 (-0.17 237 
GCP units/year, 95% CI -0.35, 0.01). For the group with peak CAM-S=3-7, there was a 238 
significant decrease in GCP score (-0.30 GCP units/year, 95% CI -0.51, -0.09). The magnitude of 239 
this change was about a third of the change observed in the highest severity grouping, peak 240 
CAM-S=8-19 (-0.82 GCP units/year, 95% CI -1.28, -0.37). These results suggest a graded 241 
association of delirium severity and the rate of cognitive decline. Compared to patients in the 242 
lowest severity group, the most severe delirium group demonstrated a 4.8-fold accelerated 243 
decline (-0.82/-0.17). A linear trend test for differences in slope across severity group was 244 
significant (p=0.009; Appendix). Moreover, the significant linear relationship between delirium 245 
severity and GCP slope remained when peak CAM-S was considered as a continuous measure 246 
(see Appendix).   247 
Table 3 shows the prevalence of proxy-rated IQCODE impairment by delirium severity 248 
group over time. Sample sizes differ between Table 3 and Table 2 because we could not always 249 
locate or interview a suitable proxy informant for every surgical patient. For those in the low 250 
severity group (peak CAM-S=0-2), there was no significant change in IQCODE impairment over 251 
time. For the other severity groups, the prevalence of IQCODE impairment increased 252 
significantly over time, with greater prevalence of IQCODE impairment with increasing delirium 253 
severity (odds ratio [OR] 1.2 (95% CI 0.99, 1.5). Similar to the results for GCP, the association 254 
with IQCODE impairment suggests a dose response (Figure 2 shows adjusted models), with the 255 
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strongest effect in the most severe group; however, the linear trend did not achieve statistical 256 
significance (p=0.07). 257 
In total, 103 participants experienced either death or nursing home placement between 6-258 
36 months. At baseline, these participants were older, fewer were married, had higher Charlson 259 
comorbidity scores, more depressive symptoms, more ADL and IADL impairment, lower GCP 260 
scores (see Appendix for detailed study sample description). They also had higher peak CAM-S 261 
scores during hospitalization relative to the 457 participants who did not die and were not placed 262 
in a nursing home. We observed increasing incidence across severity groups (15%, 20%, 28% 263 
for peak CAM-S 0-2, 3-7, and 8-19, respectively) and a trend which approached but did not 264 
achieve statistical significance (p=0.06) (see Appendix for additional details).     265 
 266 
DISCUSSION   267 
In this large prospective cohort of older persons without baseline dementia undergoing 268 
elective surgery, patients experiencing higher delirium severity had greater rates of long-term 269 
cognitive decline by serial neuropsychological testing (GCP). This finding was supported by 270 
analyses examining the proxy IQCODE and risk of death or nursing home placement. These 271 
findings suggest a dose-response effect where the risk of poor long-term outcomes increases 272 
progressively across severity groups. The risk for greater cognitive decline was substantial and 273 
statistically significant in the highest delirium severity grouping.  274 
 The findings utilizing the composite GCP measure demonstrated a 4.8-fold more rapid 275 
decline between the highest and lowest severity groups. The per-year change in GCP in the long-276 
term (months 2-36) is about -0.17 GCP units/year, or -0.02 (-0.17/7.30) standard deviation (SD) 277 
units/year in the lowest delirium severity group (peak CAM-S 0-2). Prior studies report declines 278 
with cognitive aging in the absence of dementia to range between -0.01 and -0.04 SD units/year 279 
[40-42]. Thus, patients with low delirium severity had a rate of cognitive decline (-0.02 SD per 280 
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year) comparable to previous studies for cognitively normal persons. By comparison, SAGES 281 
patients with moderate severity declined by -0.30 GCP units/year (-0.04 SD units) and those with 282 
the most severe delirium declined by -0.82 GCP units/year (-0.11 SD units). Our findings align 283 
with prior work in patients undergoing coronary-artery bypass grafting in which the pattern of 284 
cognitive decline is predicted by early postoperative cognitive decline (POCD) [42], 285 
underscoring similarities in the long-term trajectories of patients with POCD and severe 286 
postoperative delirium. 287 
  While the substantial short-term adverse outcomes of delirium are well-recognized, our 288 
results hold important implications for the longer-term prognosis of delirium. This represents a 289 
paradigm shift in the way delirium is currently viewed. Delirium may not be transient and 290 
reversible with only acute complications; rather, more severe delirium cases may be 291 
associated with long-term and potentially permanent cognitive decline. Furthermore, this work 292 
suggests the need to target patients with high delirium severity for strategies to prevent 293 
progressive cognitive decline, and potentially increased risk for dementia. 294 
 While prior work has established the association of incident delirium with long-term 295 
cognitive decline [7-10], these findings are novel in demonstrating that delirium severity is 296 
directly associated with long-term cognitive decline in an exposure-response fashion. We 297 
acknowledge that causal associations cannot be determined from this observational study. 298 
However, the observed exposure-response relationship is a critical first step in demonstrating a 299 
direct association between delirium severity and long-term cognitive decline, and is an important 300 
criterion used in causal inference for epidemiologic studies [43]. The novelty of our study also 301 
includes both the use of a comprehensive measure of delirium severity (peak CAM-S scores, 302 
reflecting the height of delirium intensity) and in the serial measurement of cognitive function 303 
over a 3-year period following surgery. We chose peak CAM-S as our outcome measure to 304 
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reflect maximal intensity of delirium; however, other measures might have been chosen (e.g., 305 
sum CAM-S [18], see Appendix). Future studies should examine other severity measures, 306 
including the Memorial Delirium Assessment Scale, Delirium Rating Scale, and Delirium Index 307 
have been associated with increased mortality [44, 45], institutionalization [46, 47], and length 308 
of stay [48]. Delirium duration has also been associated with increased death rates, increased 309 
ventilator-dependent days, and intensive care unit stay [49-52]. The current study is innovative 310 
in enabling examination of exposure-response relationships by examining outcomes across 311 
multiple levels of severity. Other strengths include the use of a large cohort with thorough data 312 
collection, careful characterization of preoperative cognition, repeated neuropsychological 313 
testing over time, standardized delirium assessments, and extended post-surgical follow-up. 314 
Additionally, exclusion of mild dementia at baseline facilitated examination of the effects of 315 
delirium severity free of this potentially confounding influence. This presented a unique 316 
opportunity to study cognitive impairment following delirium occurring largely in non-317 
cognitively impaired older patients. Finally, the careful correction for learning effects over time 318 
represents another important advance. 319 
Several caveats about this study deserve mention. Although we controlled for learning 320 
effects, patients recovered back to or above baseline levels at 2 months, suggesting that: 1) 321 
longer-term follow-up is critical to understanding the trajectory of cognitive recovery post-322 
surgery, and 2) this control for learning effects was either incomplete or that patients had 323 
depressed cognitive levels at baseline, which may have been due to preadmission pain 324 
medications such as narcotics. We encountered missing data due to deaths and drop-outs, and 325 
addressed these in sensitivity analyses to assure the robustness of our conclusions (Appendix). 326 
Despite using reasonable and established methods, participants who developed delirium may 327 
have been on a downward cognitive trajectory prior to surgery, and we could not completely rule 328 
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out preclinical (asymptomatic) dementia, or clinically presymptomatic, but AD biomarker 329 
positive dementia (as defined by stage 1 of the 2011 NIA criteria for AD), at baseline. Moreover, 330 
the observation of a lower GCP in this group was anticipated, given that baseline cognitive 331 
impairment has been long recognized as an important risk factor for delirium. Perhaps the more 332 
intriguing observation is that participants on average improved back to baseline at 2 months 333 
following delirium, and successively declined from 2 to 36 months suggesting a degree of initial 334 
resiliency that would not be expected for those with underlying dementia. Similarly, we 335 
acknowledge that inclusion of the pending follow-up visits may influence our current findings. In 336 
general, we do not anticipate a substantial change in our study conclusions upon incorporating 337 
the remaining visits since GCP scores observed for the two lowest delirium severity groups (peak 338 
CAM-S 0-2 and 3-7) are relatively stable from around month 24 and onwards, and the GCP 339 
scores appear to continue declining in the highest delirium severity group (peak CAM-S 8-19). 340 
An additional caveat includes the fact that patients with delirium had lower GCP scores at 341 
baseline than those without delirium, although both groups were above the U.S. population mean 342 
GCP score=50. It may be that patients who were undergoing cognitive decline prior to surgery 343 
may represent individuals at greatest risk for experiencing more severe delirium; however, with 344 
only one preoperative cognitive assessment, we were unable to directly test this possibility. We 345 
attempted to investigate this possibility by matching patients in the highest severity group (peak 346 
CAM-S 8-19) with patients in the other two severity groups on preoperative GCP (see Appendix 347 
for Methods and detailed Results), and found the pace of decline was faster in the highest 348 
severity group (peak CAM-S 8-19; slope -0.09 SD/year) than in the peak CAM-S 3-7 group 349 
(slope -0.04 SD/year), which was in turn faster than the peak CAM-S 0-2 group (slope -0.02 350 
SD/year). We acknowledge that the study population represents a highly educated sample with 351 
relatively low racial diversity from a single city; however, the diversity characteristics of our 352 
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sample (92% white) are representative of the Boston area (2008-2012 census data) [53]. It is 353 
important to note that our choice of a dementia-free, relatively robust elective surgical population 354 
may have influenced our findings. Patients with dementia might be more vulnerable to decline 355 
after milder cases of delirium [5]. Finally, our use of the peak CAM-S does not discern 356 
hypoactive from hyperactive delirium, which may have differing prognoses.  357 
While delirium has previously been considered a transient condition of only short-term 358 
significance, our results suggest that for patients with moderate to severe delirium, the declines 359 
in cognition may be both substantial and long-term, and most notably exceeds the rate of decline 360 
observed for patients with dementia. Although it remains critical to prevent and treat all delirium 361 
to minimize well-documented short-term adverse outcomes, our results suggest the need for 362 
more targeted strategies (e.g., cognitive rehabilitation, as used for patients with brain injuries 363 
[54]) in patients with higher delirium severity to prevent long-term cognitive decline. Our 364 
findings underscore the need to heighten efforts to better understand the risk factors and 365 
pathophysiology of delirium of moderate to high severity, and to better target prevention and 366 
management strategies to mitigate the long-term and potentially permanent adverse sequelae 367 
associated with this common, morbid, and costly geriatric syndrome.   368 
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       aThe patient, with a peak CAM-S score of 2, had chart delirium 
 b Delirium status was determined with daily interviews rating the Confusion Assessment Method,  
 augmented by a validated chart review 
 cSpearman rank correlation coefficient indicates the correlation of each variable with the peak CAM-S score 
 ADL = Activities of Daily Living, impairment indicated by human assistance to complete any activity 
      CAM-S = Confusion Assessment Method-Severity 
 GCP = General Cognitive Performance, composite measure of neuropsychological measures reflecting  
 cognitive domains vulnerable to delirium, see text for details  
  GDS15= Geriatric Depression Scale 15 point version, range (0-15), higher is worse; a score 6 and above is considered impaired  
      IADL = Instrumental Activities of Daily Living, impairment indicated by human assistance to complete any activity 
       IQCODE = Informant Questionnaire on Cognitive Decline in the Elderly, score >3.2 indicates cognitive impairment 
       3MS = Modified Mini-Mental State Exam, range (0-100), lower score indicates impairment; a score ≤84 is considered impaired 
       SAGES = Successful Aging after Elective Surgery Study 
      SD= standard deviation. 
      The Charlson comorbidity score ranged from 0-35, with higher scores indicating more comorbidity.	
Table 1.  Description of Study Sample 
   Peak CAM-S score   
Rank 
Correlationc 
 Full Sample  0 – 2  3 – 7  8-19  
Characteristic (N = 560)  (N = 244)  (N = 248)  (N = 68)  
Age - mean (SD) 76.7 (5.2)  76.0 (4.7)  77.2 (5.7)  
77.0 
(4.6) 
 0.09 
Female – n (%) 326 (58)  147 (60)  141 (57)  38 (56)  -0.04 
Nonwhite – n (%) 42 (8)  12 (5)  25 (10)  5 (7)  0.07 
Education – mean years  (SD) 15.0 (2.9)  15.6 (2.8)  14.4 (2.9)  
14.6 
(3.0) 
 -0.17 
Married – n (%) 332 (59)  142 (58)  151 (61)  39 (57)  0.01 
Lives Alone – n (%) 167 (30)  79 (32)  66 (27)  22 (32)  -0.03 
Charlson score - n (%)         0.12 
0 257 (46)  126 (52)  102 (41)  29 (43)   
1 139 (25)  62 (25)  66 (27)  11 (16)   
2+ 164 (29)  56 (23)  80 (32)  28 (41)   
GDS15 score - n (%)         0.18 
0 - 5 489 (88)  225 (93)  214 (86)  50 (74)   
6 - 15 69 (12)  17 (7)  34 (14)  18 (26)   
GCP score - mean (SD) 57.6 (7.3)  60.5 (6.7)  55.8 (7.3)  
53.8 
(5.6) 
 -0.36 
3MS score - n (%)         0.13 
85-100 523 (93)  237 (97)  225 (91)  61 (90)   
71-84 37 (7)  7 (3)  23 (9)  7 (10)   
Proxy IQCODE (baseline) - n (%)         0.104 
Not Impaired 430 (78)  198 (83)  183 (76)  49 (72)   
Impaired 118 (22)  40 (17)  59 (24)  19 (28)   
ADL impairment – n (%) 42 (8)  10 (4)  24 (10)  8 (12)  0.12 
IADL impairment – n (%) 152 (27)  51 (21)  77 (31)  24 (35)  0.13 
Surgery type - n (%)         -0.03 
Orthopedic 454 (81)  196 (80)  201 (81)  57 (84)   
Vascular 35 (6)  11 (5)  18 (7)  6 (9)   
General 71 (13)  37 (15)  29 (12)  5 (7)   
Deliriumb - n (%)          
None 426 (76)  243 (100)  181 (73)  2 (3)   
Delirium 134 (24)  1a (0)  67 (27)  66 (97)   
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Table 2: Corrected GCP Scores over Time 
 
  Peak CAM-S score 
Visit Full Sample _____0 – 2_____ _____3 – 7_____ _____8 – 19____ 
month N Mean (SD) N Mean (SD) N Mean (SD) N Mean (SD) 
0 560 57.6 (7.3) 244 60.5 (6.7) 248 55.8 (7.3) 68 53.8 (5.6) 
1 548 56.8 (7.9) 243 60.0 (6.9) 242 55.0 (7.9) 63 51.4 (5.8) 
2 536 58.0 (7.9) 238 60.9 (7.1) 237 56.2 (8.1) 61 53.8 (5.3) 
6 528 58.2 (7.5) 237 61.0 (6.5) 230 56.4 (7.9) 61 54.2 (6.1) 
12 511 58.4 (7.6) 227 61.2 (7.0) 224 56.8 (7.6) 60 53.9 (5.4) 
18 499 58.3 (8.0) 219 61.5 (6.9) 222 56.5 (7.9) 58 52.7 (7.2) 
24 474 58.2 (8.0) 213 61.2 (6.8) 211 56.4 (8.1) 50 52.4 (7.2) 
30 325 57.5 (8.2) 132 60.7 (7.5) 152 56.1 (7.9) 41 52.4 (7.3) 
36 312 57.1 (8.4) 123 60.6 (7.4) 141 55.8 (8.2) 48 51.8 (7.7) 
 
CAM-S = Confusion Assessment Method-Severity 
 GCP = General Cognitive Performance, composite measure of neuropsychological measures reflecting  
 cognitive domains vulnerable to delirium, see text for details  
Notes: All postoperative GCP values corrected for practice effects (see text for details). The number of participants 
completing each the interview/the number of participants eligible for the interview for each time point follows with 
amount of attrition from the prior time point in brackets. Baseline: 560/560 [0]; Month 1: 548/552 [8]; Month 2: 
536/546 [6]; Month 6: 528/539 [7]; Month 12: 511/527 [8]; Month 18: 499/516 [8]; Month 24: 474/489 [13]; Month 
30: 325/342 [6]; Month 36: 312/316 [1] 
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Table 3: Empirically Observed Prevalence of Proxy IQCODE Impairment over Time 
 
 
 CAM-S = Confusion Assessment Method-Severity 
 IQCODE = Informant Questionnaire on Cognitive Decline in the Elderly  
Since the IQCODE is proxy-rated, the sample sizes in this table reflect the availability of proxy-informants 
over time; 12 patients did not have any proxies available at baseline, yielding a total proxy sample of 
N=548 
N=total possible sample, n=number with proxy IQCODE impairment 
  
	 	 	 Peak CAM-S score	
Visit Full Sample ___0 – 2___ ___3 – 7___ ___8 – 19___ 
month N n (%) N n (%) N n (%) N n (%) 
0 548 118 (22) 238 40 (17) 242 59 (24) 68 19 (28) 
6 514 135 (26) 229 46 (20) 226 67 (30) 59 22 (37) 
12 487 130 (27) 217 49 (23) 218 60 (28) 52 21 (40) 
18 480 142 (30) 208 49 (24) 217 66 (30) 55 27 (49) 
24 452 125 (28) 202 46 (23) 205 61 (30) 45 18 (40) 
30 314 101 (32) 127 28 (22) 145 54 (37) 42 19 (45) 
36 287 94 (33) 118 25 (21) 126 48 (38) 43 21 (49) 
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Figure 1 
 
Title: Trajectory of General Cognitive Performance by Estimated Peak Confusion Assessment 
Method-Severity (CAM-S) Score 
 
Legend: Figure 1 demonstrates the relationship between estimated general cognitive performance 
(GCP) and time following surgery (months) by delirium severity group. The model is adjusted 
for baseline GCP, age, gender, non-white race, education, Charlson score, Geriatric Depression 
Scale score, instrumental Activities of Daily Living (IADL) impairment, surgery type, and proxy 
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) impairment. For each 
group, we plot the model-implied trajectory and a solid gray reference line at the baseline value. . 
The amount of punctuation (acute decline at one month), recovery (up to two months), and long-
term decline (two to 36 months) is shown by each CAM-S severity group, 0-2 (dashed black 
line), 3-7 (dot-dashed black line) and 8-19 (solid gray line). In the acute (punctuation) phase, all 
groups decline with the most severe group declining the most.  This is followed by recovery of 
cognitive performance, with the less severe groups recovering (at two months) past their baseline 
(0 months) GCP score, and those in the most severe group showing an incomplete return to 
baseline. Over long-term follow-up, the less severe groups gradually decline in GCP 
performance, whereas the most severe group demonstrates a faster pace of decline. 
Figure 1  
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Figure 2 
 
Title: Predicted Prevalence of IQCODE impairment by delirium severity group and study month 
 
Legend: Figure 2 demonstrates the relationship between the prevalence of proxy Informant 
Questionnaire on Cognitive Decline in the Elderly (IQCODE) impairment (score ≥ 3.2) over 
time (study month) following surgery, calculated using a mixed effects generalized linear model. 
The odds ratios (OR) are computed from models that controlled for age, gender, non-white race, 
education, Charlson score, Geriatric Depression Scale score, and surgery type; and thus differ 
from the ORs derived from the numbers presented in Table 3. Model-implied (or expected) 
proportions with IQCODE impairment given mean values on covariates are presented in the 
table. Odds ratios (and 95% confidence bands) illustrate the size and precision of estimates of the 
delirium severity group by time (in years following surgery) interaction effects. Over time, all 
groups have increasing probability of being classified as impaired on the IQCODE (p=.05). The 
per-year odds of IQCODE ≥3.2 for this group is about two times greater than that observed for 
the lowest delirium severity group.   
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Overview 
The information in this Supplemental Appendix is provided to: (1) describe our approach for 
minimizing learning and practice (retest) effects; (2) describe our statistical modeling approach to 
test our hypotheses regarding the association of delirium and cognitive change following surgery 
with detailed model results; (3) assess the limits of our inferences in the presence of differing 
assumptions about missing data [sensitivity analysis 1];  (4) assess the relationship between long-
term cognitive decline and an alternate measure of delirium severity, sum of CAM-S scores 
[sensitivity analysis 2]; (5) describe our analytic sample and follow-up success rates; (6) describe 
the study sample by death or nursing home placement status; (6) illustrate the association between 
peak CAM-S as a continuous variable and GCP slope; and (7) consideration of a matched analysis
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Consideration of Practice and Retest Effects 
 
Practice and retest effects are pervasive and challenging in studies with repeated measures of 
cognition over time. No clear consensus exists for the optimal handling of practice (and retest) 
effects in statistical analyses.1 The technique we uses was first used in the International Study on 
Postoperative Cognitive Dysfunction (ISPOCD), and as implemented here is quite similar to the 
modeling of boost retest effects, described previously,2 which lends further support for its 
application here. Our approach involves assessing a comparison sample (n = 119) of otherwise 
comparable persons (patients in a primary care clinic at one of our study sites) with the same tests 
and on the same schedule of assessment. The mean performance of this sample at each time point is 
used to center the observed scores seen in our surgical sample at matching time points. The 6 month 
assessment in our comparison sample is used as the centering point for all subsequent observations 
in our surgical sample. The 6 month cutoff was utilized, since most studies consider that practice 
effects have leveled off by this time. This approach relies upon the assumption that differences in 
the mean across the repeat performances in the comparison sample represent the mean practice or 
retest effect free of normative cognitive change. We considered this assumption reasonable given 
the very short time interval between assessments in a relatively healthy comparison group.  
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Statistical Model 
 
Our statistical modeling approach involved the use of generalized linear mixed effects 
models, or random effects models, that account for: (1) the dependence of pre-operative cognitive 
performance (y0) on preoperative baseline and background variables (z), (2) the dependence of the 
severity level of delirium (dc) on background variables (z) and pre-operative level of cognitive 
functioning (y0), and (3) the dependence of follow-up cognitive performance (yt) on baseline 
(preoperative) cognitive performance  (y0), delirium (dc) and background variables (z). A graph 
summarizing the temporal ordering (left to right) and dependence relationships is shown in Figure 
S1. 
 
 
Figure S1. A path diagram illustrating the estimated model. 
Variables include background and pre-operative baseline variables 
considered as potential confounders (z), baseline pre-operative 
cognitive performance (General Cognitive Performance, GCP; y0), 
the occurrence and level of delirium severity following surgery 
(dc), and follow-up cognitive performance (through the scheduled 
36 month follow-up; y1- y9). Change in GCP (y) is modeled with a 
piecewise linear latent growth curve model, where the “pieces” 
refer to “boost” effects at one and two months capturing initial 
decline and recovery following surgery (which occurs between y0 
and y1). Latent variables (enclosed in circles) capture baseline (i1), 
and initial decline, recovery, and long-term slope (i2, i3, s), as well 
as a categorical known class latent mixture variable (dc) that is 
identical to observed dc, the post-operative delirium severity group. 
We regress dc on i with multinomial logistic regression, which 
captures the dependency of delirium and its severity on baseline 
cognitive function. We also regress baseline cognition and 
delirium severity group, as well as the three slope pieces on 
background and potentially confounding variables. Finally, we also 
regress the immediate decline, recovery, and long-term slope 
effects on baseline.  
 
We are primarily interested in the direct effect of delirium severity group (dc) on follow-
up GCP, General Cognitive Performance (yt). The estimated model is one that includes linear 
regression, multinomial logistic regression, and piecewise linear mixed effect regression models, 
all estimated simultaneously in a multiple group or known class mixture model. Baseline 
cognitive performance regressed on background variables are handled with linear regression. The 
regression of postoperative delirium severity group on preoperative cognition and background 
variables is handled with logistic regression, as the outcome membership in severity group dc) is 
a set of nominal outcomes (0 = in lowest severity class, 1 = in severity class c). The piecewise 
linear mixed effect model for follow-up cognition includes two (fixed) pieces for performance at 
1 and 2 months, parameter estimates for which describe the punctuation and recovery effects, 
respectively, following surgery and/or delirium. Change over time from scheduled study month 2 
through 36 was modeled with a mixed effect model, with change over time included as a linear 
random effect. We considered a quadratic effect to model follow-up time but observed only a 
small improvement to information criteria (difference in Bayesian information criterion <2, 
considered an insignificant effect4), and the difference in the Akaike information was criteria 
<1%. Thus, we considered the gain in explanatory power insufficient to justify the added 
complexity.  
 
Parameter estimates were obtained with Mplus software version 7.4 (Muthén & Muthén, 
Los Angeles, CA) using robust maximum likelihood (ML) parameter estimation. The mixed 
effect model included random effects for preoperative baseline and linear slope, meaning that 
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these parameters were modeled with variances and covariances. Piecewise effects for 
punctuation and retest were modeled as fixed effects. The modeling approach does not make 
explicit reference to the covariance structure of the repeatedly observed outcome (cognitive 
performance, y0, yt) as in other mixed effect modeling approaches, but can be conceptualized as 
unstructured and accounted for by the variances in baseline, linear slope, and also by background 
variables and delirium severity group (z, dc). ML parameter estimation makes use of all available 
information, and the parameter estimates reflect the most likely parameter estimates for persons 
with incomplete data over the follow-up period. We had missing data for 2 participants for one 
background variable (Geriatric Depression Scale, GDS score).  The other background variables 
(z, age, gender, non-white race, education, Charlson score, instrumental activities of daily living 
[IADL], and surgery type) or postoperative delirium (dc) did not have missing data.  Bayesian 
estimation methods were used to impute values for the missing data. 
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Detailed Model Results 
 
 Below, we provide detailed model results, expanded beyond what is displayed in the 
main manuscript. We omit the effects of covariates here, since all covariates were mean-centered 
and therefore do not influence the computation of expected values. General cognitive 
performance (GCP) is centered at the overall sample mean in the model, and estimates in all 
tables are transformed to reflect the full scale of the GCP.  
 
Table S1. Detailed Model Results Reporting the Association between Delirium Severity 
(Peak Confusion Assessment Method-Severity score) and General Cognitive Performance 
(N=560) 
 
Model Parameter Estimate 95% CI P-value 
Effect of baseline GCP in … 
   GCP punctuation  0.53 ( 0.11, 0.93) .013 
GCP recovery -0.11 (-0.47, 0.26) .565 
GCP slope, Months 2 – 36 (per 
year) 0.18 ( 0.01, 0.37) .063 
    
Estimated means for latent growth model effects by Delirium (peak 
CAM-S) severity group 
CAM-S Peak 0-2 
   GCP Punctuation  -0.65 (-1.06, -0.23) .002
GCP Recovery  1.15 ( 0.79, 1.50) <.001 
GCP Slope, Months 2 - 36 (per 
year) -0.17 (-0.35, 0.01) .073 
CAM-S Peak 3-7 
  
 
GCP Punctuation  -0.78 (-1.19, -0.28) <.001 
GCP Recovery  1.37 ( 0.99, 1.76) <.001 
GCP Slope, Months 2 - 36 (per 
year) -0.30 (-0.51, -0.09) .005 
CAM-S Peak 8-19 
  
 
GCP Punctuation  -2.28 (-3.25, -1.31) <.001 
GCP Recovery  2.55 ( 1.78, 3.31) <.001 
GCP Slope, Months 2 - 36 (per 
year) -0.82 (-1.28, -0.37) <.001 
SAGES = Successful Aging after Elective Surgery, GCP = general cognitive performance,  
CAM-S = Confusion Assessment Method-Severity score, CI = confidence interval   
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Sensitivity Analysis 1: Assessing Robustness of Findings to Extreme Assumptions of Missing 
Data Due to Drop-Out, Death, or Institutionalization      
 
There was incomplete follow-up data through the 36 month follow-up visit.  Most of this is due 
to the rolling enrollment of the study design.  However, there were some cases of death and 
dropout. 
 
Table S2. Peak Confusion Assessment Method-Severity scores by study status 
 
 CAM-S Peak Scores 
 
Overall 0-2 3-7 8-19 
Study status n % n % n % n % 
In study 496 ( 89) 225 ( 92) 218 ( 88) 53 ( 78) 
Death/dropout 64 ( 11) 19 ( 8) 30 ( 12) 15 ( 22) 
Total 560 244 248 68 
CAM-S = Confusion Assessment Method-Severity 
 
 The difference in proportion across all delirium severity groups is significant (p = .004).  
Our main analysis reported in the manuscript summarizes maximum likelihood parameter 
estimates, which are theoretically unbiased under the assumption that the missing data 
mechanism is missing at random (MAR).  This means that the reason why individuals are 
missing is not due to the value on the outcome (GCP) that would have been observed, had it been 
observed (conditional on the effect of observed data). Most of the missing data can be safely 
assumed to be missing completely at random (MCAR) because it is due to the date of enrollment 
and no other factor.  However, it is possible that for some of the people who dropped out due to 
death or institutionalization the MAR assumption is overly restrictive.  To address this, we 
performed a set of sensitivity analyses to examine the range of possible effects of a non-
ignorable missing data pattern for those participants for whom we are assuming MAR holds. In 
both sensitivity analyses, we impute values for missing data.  We do so under two conditions that 
represent extreme conditions of possible missing data mechanisms that would be most beneficial 
and most harmful to our hypothesis that delirium severity influences long-term cognitive decline.  
Both analyses follow a similar framework.  Factor scores for each participant’s baseline, decline, 
recovery, and long-term slope were estimated from the adjusted model shown in the main 
manuscript.  The long-term slope estimates were modified by either adding or subtracting an 
amount proportional to the standard deviation of the long-term slopes.  The original baseline, 
decline, recovery, and the modified long-term slope factor scores were then used to calculate the 
missing outcomes for subjects that died or dropped out. 
 
 Best case scenario: This scenario provides conditions that are most favorable to our 
hypotheses.  The long-term slope factor scores were modified so that the delirium severity 
groups would diverge.  The participants in the peak Confusion Assessment Method-Severity 
(CAM-S) 0-2 group had 1 standard deviation (SD) added to their score.  The participants in the 
CAM-S 3-7 group had 0.5 SD added to their score.  The participants in the CAM-S 8-19 group 
had 0.5 SD subtracted from their score.   
 Worst case scenario: This scenario provides conditions that are least favorable to our 
hypotheses.  The long-term slope factor scores were modified so that the delirium severity 
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groups would converge.  The participants in the CAM-S 0-2 group had 1 SD subtracted from 
their score.  The participants in the CAM-S 3-7 group had 0.5 SD subtracted from their score.  
The participants in the CAM-S 8-19 group had 0.5 SD added their score.  
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Table S3. Detailed Model Results Reporting the Association between Delirium Severity (peak 
Confusion Assessment Method-Severity score) and General Cognitive Performance, Given 
Extreme Assumptions of Missing Data 
 
 
Baseline Decline Recovery Long-term slope 
 
Estimate 95% CI Estimate 95% CI Estimate 95% CI Estimate 95% CI 
Original model (for reference) 
      Baseline GCP 
  
0.53 ( 0.11, 0.93) -0.11 (-0.47, 0.26) 0.18 ( -0.01, 0.37) 
CAM-S Peak:         
   0-2 57.61 (57.12, 58.09) -0.65 (-1.06, -0.23) 1.15 ( 0.79, 1.50) -0.17 (-0.35, 0.01) 
   3-7 57.61 (57.12, 58.09) -0.78 (-1.20, -0.35) 1.37 ( 0.99, 1.76) -0.30 (-0.51, -0.09) 
   8-19 57.61 (57.12, 58.09) -2.28 (-3.25, -1.31) 2.55 ( 1.78, 3.31) -0.82 (-1.28, -0.37) 
Sensitivity analysis: best case scenario 
      
Baseline GCP 
 
0.50 ( 0.10, 0.88) -0.13 (-0.47, 0.21) 0.20 ( 0.03, 0.37) 
CAM-S Peak:        
   0-2 57.61 (57.12, 58.09) -0.64 (-1.04, -0.24) 1.12 ( 0.77, 1.47) -0.09 (-0.26, 0.07) 
   3-7 57.61 (57.12, 58.09) -0.80 (-1.22, -0.39) 1.35 ( 0.98, 1.72) -0.26 (-0.44, -0.06) 
   8-19 57.61 (57.12, 58.09) -2.30 (-3.24, -1.36) 2.57 ( 1.86, 3.28) -0.98 (-1.38, -0.57) 
Sensitivity analysis: worst case scenario 
      Baseline GCP  0.50 ( 0.10, 0.88) -0.14 (-0.48, 0.20) 0.26 ( 0.09, 0.43) 
CAM-S Peak:        
   0-2 57.61 (57.12, 58.09) -0.64 (-1.04, -0.24) 1.17 ( 0.83, 1.52) -0.28 (-0.45, -0.12) 
   3-7 57.61 (57.12, 58.09) -0.80 (-1.22, -0.39) 1.38 ( 1.01, 1.75) -0.38 (-0.58, -0.19) 
   8-19 57.61 (57.12, 58.09) -2.30 (-3.25, -1.36) 2.49 ( 1.78, 3.20) -0.69 (-1.09, -0.28) 
GCP = general cognitive performance, CAM-S = Confusion Assessment Method-Severity score,  
CI = confidence interval 
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Interpretation of Results for Sensitivity Analysis 1  
 
 For the GCP analysis, in both the best and worst case scenario, we arrive at comparable 
decisions regarding the effect of delirium severity in long term slope (last column in Table S3).  
In the observed data, best case, and worst case scenario the slope is declining among all severity 
groups over the 36 month interval.  In the best case scenario (i.e., those persons who dropped out 
were on a steeper cognitive decline trajectory than predicted by their observed data) the dose-
response effect is more pronounced than in the observed data.  In the worst case scenario (i.e., 
persons who dropped out were on a much lower decline in cognitive functioning relative to what 
would be inferred from their observed data), the dose-response effect is more subtle.  These 
differences in the patterns of results set boundaries on the range of plausible effects of delirium 
in our study.  The original maximum likelihood results reported in the top segment, and in the 
main manuscript, reflect our best estimate of the population parameters, and we believe that if 
the missing data mechanism is not MAR, the results would be somewhere between the observed 
results and those of the best case scenario.  That is to say, it is more plausible that persons with 
more severe delirium who went on to die or leave the study due to institutionalization would 
have steeper cognitive decline slopes than what might be expected given their observed data, 
rather than shallower cognitive decline slopes.  Therefore, we believe that if anything our 
maximum likelihood results are accurate or perhaps somewhat conservative estimates of the true 
population parameters. 
 
  
 42 
 
Sensitivity Analysis 2: Assessing the Relationship between Sum of CAM-S Scores and Long-
Term Cognitive Decline  
 
Table S4. Relationship of Peak Confusion Assessment Method-Severity (CAM-S) to Sum of 
all CAM-S Scores 
	 Peak	CAM-S	score	 	
Sum	CAM-S	score	 0-2	 3-7	 8-19	 Total	
0-2	 112	 0	 0	 112	
3-16	 131	 222	 14	 367	
17-max	 1	 26	 54	 81	
Total	 244	 248	 68	 560	
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Table S5. Sum of CAM-S Scores by Corrected GCP Scores over Time 
 
   Sum CAM-S score 
Visit Full Sample  0 – 2  3 – 16  17 – max 
Month N Mean (SD) 
 
N 
Mean 
(SD) 
 
N Mean (SD) 
 
N Mean (SD) 
0 560 57.6 (7.3)  112 60.9 (6.2)  367 57.6 (7.3)  81 53.3 (6.1) 
1 548 56.8 (7.9)  112 60.3 (6.2)  359 57.1 (7.8)  77 50.6 (6.5) 
2 536 58.0 (7.9)  109 61.4 (6.3)  352 58.1 (8.0)  75 52.6 (6.2) 
6 528 58.2 (7.5)  109 61.4 (6.1)  347 58.2 (7.6)  72 53.4 (6.9) 
12 511 58.4 (7.6)  105 61.7 (6.6)  334 58.5 (7.6)  72 53.3 (6.3) 
18 499 58.3 (8.0)  104 61.5 (6.7)  323 58.6 (7.7)  72 52.2 (7.7) 
24 474 58.2 (8.0)  101 61.3 (6.2)  311 58.4 (7.9)  62 51.9 (7.9) 
30 325 57.5 (8.2)  67 61.1 (7.2)  213 57.3 (8.2)  45 52.8 (7.4) 
36 312 57.1 (8.4)  62 61.4 (7.3)  201 57.1 (8.2)  49 52.0 (7.8) 
	
CAM-S	=	Confusion	Assessment	Method-Severity	
GCP	=	General	Cognitive	Performance	
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Table S6. Empirically Observed Prevalence of Proxy IQCODE Impairment over Time 
 
	 	 	   Sum CAM-S score	
Visit Full Sample  0 – 2  3 – 16  17 – max 
month N n (%)  N n (%)  N n (%)  N n (%) 
0 548 118 (22)  111 20 (18)  356 71 (20)  81 27 (33) 
6 514 135 (26)  107 17 (16)  336 91 (27)  71 27 (38) 
12 487 130 (27)  102 15 (15)  320 89 (28)  65 26 (40) 
18 480 142 (30)  99 12 (12)  311 96 (31)  70 34 (49) 
24 452 125 (28)  97 20 (21)  296 82 (28)  59 23 (39) 
30 314 101 (32)  65 10 (15)  203 67 (33)  46 24 (52) 
36 287 94 (33)  59 10 (17)  184 61 (33)  44 23 (52) 
 
CAM-S = Confusion Assessment Method-Severity 
IQCODE = Informant Questionnaire on Cognitive Decline in the Elderly  
N=total possible sample, n=number with proxy IQCODE impairment   
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Figure S2. Trajectory of Estimated General Cognitive Performance by Sum of Confusion 
Assessment Method-Severity (CAM-S) Groups 
 
 
 
 
Figure S2 Legend: 
Figure S2 demonstrates the relationship between estimated general cognitive performance (GCP) 
and time following surgery (months, natural log scale) by delirium severity groups.  The model 
is adjusted for baseline GCP, age, gender, non-white race, education, Charlson score, Geriatric 
Depression score, instrumental activities of daily living (IADL) impairment, surgery type, and 
proxy Informant  Questionnaire on Cognitive Decline in the Elderly (IQCODE) impairment. The 
solid horizontal line indicates the average GCP score prior to surgery.  Delirium severity group is 
observed after baseline, and is dependent on baseline, and therefore the figure is plotted showing 
no mean difference in GCP at baseline by delirium severity group. The amount of punctuation 
(acute decline at one month), recovery (up to two months), and long-term decline (two to 36 
months) is shown by each CAM-S severity group, 0-2 (dashed black line), 3-16 (dot-dashed 
black line) and 17-max (solid grey line). In the acute (punctuation) phase, all groups decline with 
the most severe group declining the most.  This is followed by recovery of cognitive 
performance, with the less severe groups recovering (at two months) past their baseline (0 
months) GCP score, and those in the most severe group showing an incomplete return to 
baseline. Over long-term follow-up, the less severe groups gradually decline in GCP 
performance, whereas the most severe group demonstrates a more accelerated rate of decline. 
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Figure S3. Predicted Prevalence of Informant Questionnaire on Cognitive Decline in the 
Elderly (IQCODE) Impairment by delirium severity group (sum CAM-S) and study month  
 
 
Figure S3 legend: 
Figure S3 demonstrates the relationship between the prevalence of proxy IQCODE impairment 
(score ≥ 3.2) over time (study month) following surgery, calculated using a mixed effects 
generalized linear model. The model controlled for: age, gender, non-white race, education, 
Charlson score, Geriatric Depression Scale score, and surgery type. Model-implied (or expected) 
proportions with IQCODE impairment given mean values on covariates are presented in the 
table. Odds ratios (and 95% confidence bands) illustrate the size and precision of estimates of the 
delirium severity group by time (in years following surgery) interaction effects. Over time, all 
groups have increasing probability of being classified as impaired on the IQCODE, but the slope 
over time is significantly (p=.02) faster only for patients with the most severe delirium (sum of 
CAM-S scores 17-max). The per-year odds of IQCODE ≥3.2 for this group is about 2.0 times 
greater than that observed for the lowest delirium severity group.   
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Table S7. Detailed Model Results Reporting the Association between Delirium Severity 
(Sum Confusion Assessment Method-Severity) and General Cognitive Performance 
(N=560) 
 
Model Parameter Estimate 95% CI P-value 
Effect of baseline GCP in … 
   GCP punctuation  0.44 ( 0.01, 0.85) .043 
GCP recovery -0.12 (-0.48, 0.23) .497 
GCP slope, Months 2 - 36 0.27 ( 0.08, 0.46) .006 
    
Estimated means for latent growth model effects by Delirium (sum 
CAM-S) severity group 
CAM-S Sum 0-2 
   GCP Punctuation  -0.74 (-1.33, -0.13) .017
GCP Recovery  1.24 ( 0.70, 1.78) <.001 
GCP Slope, Months 2 - 36  -0.18 (-0.42, 0.07) .167 
CAM-S Sum 3-16 
  
 
GCP Punctuation  -0.60 (-0.94, -0.25) .001 
GCP Recovery  1.23 ( 0.93, 1.53) <.001 
GCP Slope, Months 2 - 36  -0.32 (-0.49, -0.15) <.001 
CAM-S Sum 17-max 
  
 
GCP Punctuation  -2.57 (-3.38, -1.75) <.001 
GCP Recovery  2.47 ( 1.77, 3.17) <.001 
GCP Slope, Months 2 - 36  -0.39 (-0.81, 0.02) .065 
 
CAM-S = Confusion Assessment Method-Severity score, GCP = general cognitive performance  
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Figure S4. STROBE Diagram of the Analytic Sample 
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*Pending interviews indicates that the subjects have not yet reached the time for their scheduled follow-up interviews. 
 
Table S8. SAGES Follow-up Success Rate 
 
 
   
  Potential Interviews 
Pending 
Interviews 
Completed Interview       
N (%) 
Refused or 
Unobtainable Deaths Drop-Outs 
1 Month 560 0 550 (98) 2 1 7 
2 Month 552 0 537 (97) 10 1 4 
6 Month 547 0 531 (97) 10 3 3 
12 Month 541 0 513 (95) 23 3 4 
18 Month 534 0 504 (94) 26 3 3 
24 Month 520 8* 478 (92) 19 10 13 
30 Month 360 145* 326 (91) 25 7 2 
36 Month 321 175* 316 (98) 2 3 0 
 50 
 
Table S9. Description of Study Sample by Death or Nursing Home Placement Status 
						 aDelirium status was determined with daily interviews rating the Confusion Assessment Method,  
 augmented by a validated chart review 
 ADL = Activities of Daily Living, impairment indicated by human assistance to complete any activity 
      CAM-S = Confusion Assessment Method-Severity 
 
 Full Sample  
Death or Nursing 
Home Placement 
 No Death or Nursing 
Home Placement 
Characteristic (N = 560)  (N = 103)  (N = 457) 
Age - mean (SD) 76.7 (5.2)  78.9 (5.6)  76.2 (4.9) 
Female – n (%) 326 (58)  62 (60)  264 (58) 
Nonwhite – n (%) 42 (8)  6 (6)  36 (8) 
Education – mean years  (SD) 15.0 (2.9)  15.1 (3.0)  14.9 (2.9) 
Married – n (%) 332 (59)  52 (50)  280 (61) 
Lives Alone – n (%) 167 (30)  36 (35)  131 (29) 
Charlson score - n (%)      
0 257 (46)  36 (25)  221 (48) 
1 139 (25)  23 (22)  116 (25) 
2+ 164 (29)  44 (43)  120 (26) 
GDS15 score - n (%)      
0 - 5 489 (88)  84 (82)  405 (89) 
6 - 15 69 (12)  19 (18)  50 (11) 
GCP score - mean (SD) 57.6 (7.3)  55.5 (7.6)  58.1 (7.1) 
3MS score - n (%)      
85-100 523 (93)  96 (93)  427 (93) 
71-84 37 (7)  7 (7)  30 (7) 
Proxy IQCODE (baseline) - n (%)      
Not Impaired 430 (78)  74 (72)  356 (78) 
Impaired 118 (22)  26 (26)  92 (21) 
ADL impairment – n (%) 42 (8)  14 (14)  28 (6) 
IADL impairment – n (%) 152 (27)  40 (39)  112 (25) 
Surgery type - n (%)      
Orthopedic 454 (81)  81 (79)  373 (82) 
Vascular 35 (6)  8 (8)  27 (6) 
General 71 (13)  14 (14)  57 (12) 
Deliriuma - n (%)      
None 426 (76)  74 (72)  352 (77) 
Delirium 134 (24)  29 (28)  105 (23) 
Peak CAM-S Score 1.7 (0.7)  1.8 (0.7)  1.7 (0.7) 
Peak CAM-S Score – n (%)      
0 – 2 244 (44)  37 (36)  207 (45) 
3 – 7 248 (44)  48 (47)  200 (44) 
8 – 19 68 (12)  18 (17)  50 (11) 
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 GCP = General Cognitive Performance, composite measure of neuropsychological measures reflecting   
 cognitive domains vulnerable to delirium, see text for details  
  GDS15= Geriatric Depression Scale 15 point version, range (0-15), higher is worse; a score 6 and above is 
considered impaired  
      IADL = Instrumental Activities of Daily Living, impairment indicated by human assistance to complete any 
activity 
       IQCODE = Informant Questionnaire on Cognitive Decline in the Elderly, score >3.2 indicates cognitive 
impairment 
       3MS = Modified Mini-Mental State Exam, range (0-100), lower score indicates impairment; a score ≤84 is 
considered impaired 
       SAGES = Successful Aging after Elective Surgery Study 
      SD= standard deviation. 
      The Charlson comorbidity score ranged from 0-35, with higher scores indicating more 
comorbidity. 
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Figure S5. Continuous Peak CAM-S Measure by GCP slope 
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Matched Analysis 
Upon the excellent suggestion of an anonymous reviewer, we tested our hypothesis that delirium 
was related to cognitive decline using a matched design. Surgical patients in the most severe 
post-operative delirium category (peak CAM-S 8-19, N=68) were matched on the basis of pre-
operative GCP score coarsened within 0.4 population SD units to patients in the peak CAM-S 3-
7 group and patients in the peak CAM-S 0-2 group (mildest group). We used coarsened exact 
matching4 to match patients in the most severe group (peak CAM-S 8-19) with at least two 
observations in the 2-36 month follow-up window to one patient from the peak CAM-S 3-7 score 
group and another patient from the peak CAM-S 0-2 group. Matching was performed on the 
basis of pre-operative GCP score binned in units of 4 (0.4 population SD units). We were able to 
match 62 of 68 patients. The mean (SD) GCP score at baseline had a mean of 54 and the 
standard deviation was 5 in each of the three groups. The pace of decline was faster in the peak 
CAM-S 8-19 group (slope -0.090 population SD units per year) than in the peak CAM-S 3-7 
group (slope -0.035 SD/year) which was faster than the peak CAM-S 0-2 group (slope -.017 
SD/year). The difference between the 0-2 group and 8-19 group was statistically significant 
(difference of .073 SD/year, P = .01) but was not different between the 0-2 group and the 3-7 
group (difference of .018 SD/year, P = .55). These findings are consistent with the findings we 
report in the manuscript using the covariate adjusted but not matched patients. 
 
Table S10. Results of Matched Analysis (N=186, n=62 in each delirium subgroup) 
 Peak CAM-S Group 
 0-2 (n=62) 3-7 (n = 62) 8-19 (n = 62) 
Baseline GCP, mean (SD) 54.2 (5.0) 54.2 (5.2) 54.2 (5.0) 
    
Mixed model results    
Difference at baseline (GCP, est, P) -- -1.1 (.31) -1.3 (.22) 
Slope from M2-M36 (GCP/y; est, P) -0.17 (.44) -- -- 
Difference in slope (GCP/y; est P) -- -0.18 (.55) -.73 (.01) 
CAM-S=Confusion Assessment Method-Severity; GCP=general cognitive performance; 
M=month; SD=standard deviation  
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